Surface modification of poly(methyl-methacrylate) with farnesol to prevent Candida biofilm formation

Lett Appl Microbiol. 2022 Oct;75(4):982-990. doi: 10.1111/lam.13772. Epub 2022 Jun 29.

Abstract

Candida albicans promotes biofilm formation on dentures, which compromises the use of poly(methyl-methacrylate) (PMMA) as a dental material. Farnesol (FAR), a natural compound that prevents C. albicans filamentation and biofilm formation, was incorporated into the PMMA matrix, to obtain antifungal PMMA_FAR materials. The tested concentrations (0·0125% and 0·4%) of FAR, 24 h after incubation on YPD agar, inhibited filamentation of C. albicans. PMMA was modified with different FAR concentrations (3-12%), and physicochemical properties, antifungal activity and cytotoxicity of these modified materials (PMMA_FAR) were tested. The presence of FAR in PMMA_FAR composites was verified by Fourier-transform infrared spectroscopy (FT-IR). Incorporation of FAR into the polymeric matrix significantly decreased hydrophilicity at all tested concentrations and significantly reduced biofilm and planktonic cells metabolic activity in the early stage of biofilm formation at ≥6% FAR in PMMA. PMMA_FAR composites with <9% FAR were non-toxic. Modification of PMMA with FAR is a good strategy for reducing C. albicans biofilm formation on dentures.

Keywords: C. albicans; antifungal activity; biofilm; farnesol; poly(methyl-methacrylate).

MeSH terms

  • Agar
  • Antifungal Agents / pharmacology
  • Biofilms
  • Candida
  • Candida albicans
  • Dental Materials
  • Farnesol* / pharmacology
  • Methacrylates
  • Polymethyl Methacrylate* / chemistry
  • Spectroscopy, Fourier Transform Infrared
  • Surface Properties

Substances

  • Antifungal Agents
  • Dental Materials
  • Methacrylates
  • Farnesol
  • Agar
  • Polymethyl Methacrylate